# Exendin-9,39 and Satiety After Bariatric Surgery

> **NCT02779075** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 29 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Saline
- **DRUG:** Exendin-9,39

## Key facts

- **NCT ID:** NCT02779075
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2019-07
- **Final completion:** 2019-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2020-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02779075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02779075, "Exendin-9,39 and Satiety After Bariatric Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02779075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*